Business Description
Arvinas Inc
NAICS : 325412
SIC : 2834
ISIN : US04335A1051
Description
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 394.06 | |||||
| Equity-to-Asset | 0.51 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 0.71 | |||||
| Beneish M-Score | -2.61 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 29.2 | |||||
| 3-Year EBITDA Growth Rate | -34 | |||||
| 3-Year EPS without NRI Growth Rate | -29.9 | |||||
| 3-Year FCF Growth Rate | -37.5 | |||||
| 3-Year Book Growth Rate | -9.9 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 31.07 | |||||
| 9-Day RSI | 28.1 | |||||
| 14-Day RSI | 28.78 | |||||
| 6-1 Month Momentum % | 186.51 | |||||
| 12-1 Month Momentum % | 51.12 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.98 | |||||
| Quick Ratio | 4.98 | |||||
| Cash Ratio | 4.9 | |||||
| Days Sales Outstanding | 20.69 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -12 | |||||
| Shareholder Yield % | 0.09 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -511.47 | |||||
| Net Margin % | -467.9 | |||||
| FCF Margin % | -446.75 | |||||
| ROE % | -69.13 | |||||
| ROA % | -31.17 | |||||
| ROIC % | -168.65 | |||||
| ROC (Joel Greenblatt) % | -2463.19 | |||||
| ROCE % | -45.3 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 20.66 | |||||
| PB Ratio | 3.34 | |||||
| Price-to-Tangible-Book | 3.33 | |||||
| EV-to-EBIT | -2.37 | |||||
| EV-to-Forward-EBIT | -1.86 | |||||
| EV-to-EBITDA | -2.41 | |||||
| EV-to-Forward-EBITDA | -1.87 | |||||
| EV-to-Revenue | 12.14 | |||||
| EV-to-Forward-Revenue | 7.94 | |||||
| EV-to-FCF | -2.72 | |||||
| Price-to-Projected-FCF | 11.99 | |||||
| Price-to-Net-Current-Asset-Value | 3.46 | |||||
| Price-to-Net-Cash | 3.57 | |||||
| Earnings Yield (Greenblatt) % | -42.19 | |||||
| FCF Yield % | -15.86 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ARVN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Arvinas Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 78.5 | ||
| EPS (TTM) ($) | -6.5 | ||
| Beta | 1.92 | ||
| Volatility % | 107.11 | ||
| 14-Day RSI | 28.78 | ||
| 14-Day ATR ($) | 1.74684 | ||
| 20-Day SMA ($) | 35.7705 | ||
| 12-1 Month Momentum % | 51.12 | ||
| 52-Week Range ($) | 13.57 - 53.08 | ||
| Shares Outstanding (Mil) | 68.31 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Arvinas Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Arvinas Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Arvinas Inc Frequently Asked Questions
What is Arvinas Inc(ARVN)'s stock price today?
The current price of ARVN is $32.37. The 52 week high of ARVN is $53.08 and 52 week low is $13.57.
When is next earnings date of Arvinas Inc(ARVN)?
The next earnings date of Arvinas Inc(ARVN) is 2024-08-08 Est..
Does Arvinas Inc(ARVN) pay dividends? If so, how much?
Arvinas Inc(ARVN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers